Additionally, the HFD-induced upregulation of Cebpa, Dgat2 and Srebp2, involved in de novo lipogenesis and NAFLD, was significantly counteracted by the synbiotic combination [30,37,50]. The gene discussed is CEBPA; the disease is metabolic dysfunction-associated steatotic liver disease.